Vanguard Capital Management
CRBU icon

Vanguard Capital Management’s Caribou Biosciences CRBU Stock Holding History

Vanguard Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.41M Buy
4,208,568
+441,340
+12% +$872K ﹤0.01% 2968
2026
Q1 		$7.16M Buy
+3,767,228
New +$6.47M ﹤0.01% 2905

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management's CRBU Position: Q2 2026 in Review

Vanguard Capital Management increased its Caribou Biosciences (CRBU) stake by 12% in Q2 2026, buying an estimated $872K and bringing the position to 4,208,568 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2968.

Vanguard Capital Management first reported a position in CRBU in Q1 2026 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Vanguard Capital Management held 4,208,568 shares of Caribou Biosciences worth $7.41M as of Q2 2026.
  • Vanguard Capital Management bought 441,340 Caribou Biosciences shares in Q2 2026, an estimated $872K.
  • Caribou Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2968 holding.
  • Vanguard Capital Management first reported a position in Caribou Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.